Understanding the genetic basis of normal and abnormal cellular processes is central to Durability to prevent and treat cancer. Investigators in the Cancer Genetics and Computational Biology Program are working to uncover genetic events involved in normal and malignant cell growth, differentiation and death, and to investigate how such events impact on cell behavior, with the ultimate goal of developing novel strategies for cancer prevention and therapy based on this information. There are five major overlapping themes within the umbrella of this new Program's research. Theme 1 - Cancer genes and signaling pathways Theme 2 - Genomic organization and gene expression in cancer Theme 3 - Papillomavirus carcinogenesis Theme 4 - Novel strategies for cancer therapy Theme 5 - Novel tools in computational biology for cancer genetics Examples of major accomplishments of the Cancer Genetics and Computational Biology Program include (a) identification of genes involved in processes important in a number of cancers including melanoma, chondrosarcoma, metastatic breast cancer and adenocarcinomas secondary to juvenile polyposis, (b) enhanced understanding of the oncogenic potential of Human Papilloma Virus extending from basic genetics to epidemiology, and (c) development of novel tools in computational biology to facilitate research in cancer genetics. The program consists of 30 members from 18 departments and 4 colleges. Current, peer-reviewed, cancer-related research, annual direct funding for this program totals $4.8 million with $885,700 coming from the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-10
Application #
7900746
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$22,487
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Chiba, Akiko; Raman, Rachna; Thomas, Alexandra et al. (2018) Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer. Clin Breast Cancer 18:144-149
Vikas, Praveen; Borcherding, Nicholas; Zhang, Weizhou (2018) The clinical promise of immunotherapy in triple-negative breast cancer. Cancer Manag Res 10:6823-6833
Alexander, Matthew S; Cullen, Joseph J (2018) Treating pancreatic cancer: more antioxidants more problems? Expert Rev Gastroenterol Hepatol 12:849-851
Lin, Jie; Adjeroh, Donald A; Jiang, Bing-Hua et al. (2018) K2 and K2*: efficient alignment-free sequence similarity measurement based on Kendall statistics. Bioinformatics 34:1682-1689
Koppenhafer, Stacia L; Goss, Kelli L; Terry, William W et al. (2018) mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells. Mol Cancer Ther 17:2676-2688
Lutgendorf, Susan K; Thaker, Premal H; Arevalo, Jesusa M et al. (2018) Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma. Cancer 124:580-586
Krishnamani, Venkatramanan; Peterson, Tabitha A; Piper, Robert C et al. (2018) Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens. J Vis Exp :
Al-Qurayshi, Zaid; Khadra, Helmi; Chang, Kristi et al. (2018) Risk and survival of patients with medullary thyroid cancer: National perspective. Oral Oncol 83:59-63
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Campbell, Hannah; Heidema, Christy; Pilarczyk, Daisy G et al. (2018) SHP-2 is activated in response to force on E-cadherin and dephosphorylates vinculin Y822. J Cell Sci 131:

Showing the most recent 10 out of 1080 publications